RCKT - Rocket Pharmaceuticals Inc
IEX Last Trade
18.81
0.030 0.159%
Share volume: 617,045
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$18.78
0.03
0.16%
Summary score
9%
Profitability
8%
Dept financing
6%
Liquidity
50%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-11.21%
Return on assets
-6.98%
Return on sales
0%
Return on invested capital
50.97%
Total debt ratio
31.94%
Debt ratio change over timeo
-1.23%
Current Ratio
18.02%
Quick Ratio
0%
Cash Position Ratio
8.94%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.2%
Return on assets
-6.22%
Return on sales
0%
Return on invested capital
-42.5%
Total debt ratio
21.97%
Debt ratio change over timeo
-1.48%
Current Ratio
13.37%
Quick Ratio
0%
Cash Position Ratio
7.76%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-9.4%
Return on assets
-6.59%
Return on sales
0%
Return on invested capital
-32.54%
Total debt ratio
24.51%
Debt ratio change over time
-1.71%
Current Ratio
12.35%
Quick Ratio
0%
Cash Position Ratio
7.89%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-89.02%
Return on assets
-91.41%
Return on sales
0%
Return on invested capital
-4.39%
Total debt ratio
-123.16%
Debt ratio change over time
-1.23%
Current Ratio
-13.91%
Quick Ratio
0%
Cash Position Ratio
-7.04%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RCKT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -11.21% | -3.05% | 11.55% | 6.27% |
| Return on assets | -6.98% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 50.97% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 39% | 71% | 65% |
| Total debt ratio | 31.94% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -1.23% | 6.09% | 6.03% | 1.53% |
| Dept financing | 8% | 50% | 43% | 14% |
| Current Ratio | 13.37% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 7.76% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 14% | 32% | 32% |
| Short-term ratios | RCKT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.2% | -25.62% | 17.94% | 7.14% |
| Return on assets | -6.22% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -42.5% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 21.97% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.48% | -23.44% | 9.66% | 0.6% |
| Dept financing | 5% | 25% | 45% | 8% |
| Current Ratio | 13.37% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 7.76% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 26% | 21% | 36% |